Laboratorios Leti

CompanySpain

Laboratorios Leti develops one asset, in phase 2 (olea europaea in allergy). Mostly other; based in Spain.

1
Asset
Furthest
Phase 2
3
Trials
0
Signals

Pipeline

1
  • olea europaea

    Allergen extract immunotherapy for desensitization against olive pollen and grass allergy.

    Phase 2, Other, allergy, rhinitis

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials3

Updated 7 Oct 2026 · 6 sources

Intelligence